![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1490, 2005-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Carboplatin-coated stent promising in cholangiocarcinoma
Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
BOND: Cetuximab a promising new agent for colorectal cancer
Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Carboplatin/cetuximab/paclitaxel: Chemo brain in an elderly patient: case report
Reactions Weekly, Vol. 1, Iss. 1353, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Atazanavir plus ritonavir promising, according to CASTLE
Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. :